Zero Protection: Chinese COVID-19 Vaccine Sinopharm Found Ineffective Against Omicron Variants
The study found that the neutralising activity against Omicron sub-variants such as BA.1, BA.2, BA.2.11, BA.2.12.1, BA.2.13, and BA.4/BA.5 "was not or only minimally detectable".
